Portal de Periódicos da CAPES

Deep Brain Stimulation in Isolated Dystonia With a GNAL Mutation

2018; Wiley; Volume: 34; Issue: 2 Linguagem: Inglês

10.1002/mds.27585

1531-8257

Harini Sarva, Richard Trosch, Zelma H. T. Kiss, Sarah Furtado, Marta San Luciano, Amanda Glickman, Deborah Raymond, Laurie J. Ozelius, Susan Bressman, Rachel Saunders‐Pullman,

Genomics and Rare Diseases

Movement DisordersVolume 34, Issue 2 p. 301-303 Letters: New Observations Deep Brain Stimulation in Isolated Dystonia With a GNAL Mutation Harini Sarva MD, Corresponding Author sarvaharini@gmail.com Department of Neurology, Mount Sinai Beth Israel Medical Center, New York, New York, USACorrespondence to: Harini Sarva, MD, Mount Sinai Beth Israel, 10 Union Square East, New York, NY 10003; sarvaharini@gmail.comSearch for more papers by this authorRichard Trosch MD, Department of Neurology, Oakland University — William Beaumont School of Medicine, Southfield, Michigan, USASearch for more papers by this authorZelma H.T. Kiss MD, PhD, Hotchkiss Brain Institute and Department of Clinical Neurosciences, University of Calgary, Calgary, Alberta, CanadaSearch for more papers by this authorSarah Furtado MD, PhD, Hotchkiss Brain Institute and Department of Clinical Neurosciences, University of Calgary, Calgary, Alberta, CanadaSearch for more papers by this authorMarta San Luciano MD, MPH, Movement Disorder and Neuromodulation Center, Department of Neurology, UCSF Medical Center, San Francisco, California, USASearch for more papers by this authorAmanda Glickman, Department of Neurology, Mount Sinai Beth Israel Medical Center, New York, New York, USASearch for more papers by this authorDeborah Raymond MS, Department of Neurology, Mount Sinai Beth Israel Medical Center, New York, New York, USASearch for more papers by this authorLaurie J. Ozelius PhD, Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Charlestown, Massachusetts, USASearch for more papers by this authorSusan B. Bressman MD, Department of Neurology, Mount Sinai Beth Israel Medical Center, New York, New York, USASearch for more papers by this authorRachel Saunders-Pullman MD, MPH, Department of Neurology, Mount Sinai Beth Israel Medical Center, New York, New York, USASearch for more papers by this author Harini Sarva MD, Corresponding Author sarvaharini@gmail.com Department of Neurology, Mount Sinai Beth Israel Medical Center, New York, New York, USACorrespondence to: Harini Sarva, MD, Mount Sinai Beth Israel, 10 Union Square East, New York, NY 10003; sarvaharini@gmail.comSearch for more papers by this authorRichard Trosch MD, Department of Neurology, Oakland University — William Beaumont School of Medicine, Southfield, Michigan, USASearch for more papers by this authorZelma H.T. Kiss MD, PhD, Hotchkiss Brain Institute and Department of Clinical Neurosciences, University of Calgary, Calgary, Alberta, CanadaSearch for more papers by this authorSarah Furtado MD, PhD, Hotchkiss Brain Institute and Department of Clinical Neurosciences, University of Calgary, Calgary, Alberta, CanadaSearch for more papers by this authorMarta San Luciano MD, MPH, Movement Disorder and Neuromodulation Center, Department of Neurology, UCSF Medical Center, San Francisco, California, USASearch for more papers by this authorAmanda Glickman, Department of Neurology, Mount Sinai Beth Israel Medical Center, New York, New York, USASearch for more papers by this authorDeborah Raymond MS, Department of Neurology, Mount Sinai Beth Israel Medical Center, New York, New York, USASearch for more papers by this authorLaurie J. Ozelius PhD, Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Charlestown, Massachusetts, USASearch for more papers by this authorSusan B. Bressman MD, Department of Neurology, Mount Sinai Beth Israel Medical Center, New York, New York, USASearch for more papers by this authorRachel Saunders-Pullman MD, MPH, Department of Neurology, Mount Sinai Beth Israel Medical Center, New York, New York, USASearch for more papers by this author First published: 10 December 2018 https://doi.org/10.1002/mds.27585Citations: 7 Relevant conflicts of interest/financial disclosures: Dr. Trosch has received consultation fees from Ipsen and speakers bureau fees from Acadia pharmaceuticals and Impax pharmaceuticals. Dr. San Luciano has received funding from the NIH. Dr. Ozelius receives patent royalties from Athena Diagnostics and funding from the NIH. Dr. Bressman has received consulting fees from Denali Therapeutics and funding from the Michael J. Fox Foundation. Dr. Saunders-Pullman receives consulting fees from Denali Therapeutics and funding from the NIH and Bigglesworth Foundation. Funding agencies: Dystonia Medical Research Foundation; NIH NIH-NINDS K02-NS073836; NIH NS087997; NIH NS099441. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinked InRedditWechat No abstract is available for this article.Citing Literature Volume34, Issue2February 2019Pages 301-303 RelatedInformation